Efficacy of iguratimod in the treatment of patients with palindromic rheumatism ineffective to methotrexate or hydroxychloroquine
IntroductionPalindromic Rheumatism (PR) is a rare form of arthritis characterized by recurrent episodes of joint and periarticular inflammation. Given the paucity of established treatment guidelines due to its rarity and complex pathogenesis, we aimed to analyze the efficacy and safety of iguratimod...
Saved in:
| Main Authors: | Mengjie Chen, Yongjun Cheng, Guiyao Jin, Yuren Tu, Qi Zhang, Chuanfu Zhang, Wenlong Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1613129/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Iguratimod efficacy in palindromic rheumatism treatment
by: Fangfang Yuan, et al.
Published: (2023-06-01) -
Comparison of the effect of iguratimod and hydroxychloroquine on regulatory B cells in the treatment of primary Sjögren’s syndrome
by: Jin-Mei Zou, et al.
Published: (2025-07-01) -
Methotrexate in the treatment of rheumatic disease
by: Marina Zinovyevna Kanevskaya, et al.
Published: (2013-12-01) -
Iguratimod improves bleomycin-induced pulmonary inflammation and fibrosis by regulating macrophage polarization through inhibiting the TLR4/NF-κB pathway
by: Huan Xu, et al.
Published: (2025-03-01) -
Tuberculosis infection in patients with rheumatic diseases under different treatments
by: Tianhui Liu, et al.
Published: (2025-05-01)